Can maternal urinary and serum carbohydrate antigen 19-9 concentrations be utilized in the diagnosis of fetal hydronephrosis?

dc.contributor.authorAkbas, M
dc.contributor.authorKoyuncu, FM
dc.contributor.authorÜlkümen, BA
dc.contributor.authorTaneli, F
dc.contributor.authorÖzdemir, H
dc.date.accessioned2024-07-18T11:49:16Z
dc.date.available2024-07-18T11:49:16Z
dc.description.abstractObjective: Fetal hydronephrosis (FH) is the most common fetal renal pathology encountered in daily obstetric practice. Urinary and scrum carbohydrate antigen 19-9 (CA 19-9) concentrations are elevated in obstructive renal pathologies. Our aim was to assess maternal urinary and serum CA 19-9 concentrations in pregnancies with FH and compare results with controls. Material and Methods: Twenty pregnancies with severe FH, 20 pregnancies with mild-moderate FH, and 20 healthy singleton pregnancies were included in this descriptive, case-control study. The diagnosis and classification of FH was based on the anterioposterior diameter of fetal renal pelvis. Maternal urinary and serum CA 19-9 concentrations were measured and compared between groups. Results: Severe FH cases had significantly higher maternal urinary CA 19-9 concentrations compared to controls (median: 75 vs 24 U/mL; respectively; p= 0.014). Concentrations of CA 19-9 did not differ between the mild-moderate FH group and control group. No statistically significant difference was found between the groups with respect to maternal serum CA 19-9 concentrations. Conclusion: Our results show that maternal urinary CA 19-9 concentration is significantly higher in pregnancies with severe FH. However, no difference was detected in serum CA 19-9 concentrations between pregnancies with severe FH, mild-moderate FH and controls. If the mechanisms of transplacental passage and maternal urinary excretion are clarified, maternal urinary CA 19-9 may be a potential marker for indicating fetal kidney damage.
dc.identifier.issn1309-0399
dc.identifier.other1309-0380
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/3892
dc.language.isoEnglish
dc.publisherGALENOS YAYINCILIK
dc.subjectTUMOR-MARKERS
dc.subjectCA-19-9
dc.subjectMANAGEMENT
dc.subjectCA-125
dc.subjectCA-50
dc.titleCan maternal urinary and serum carbohydrate antigen 19-9 concentrations be utilized in the diagnosis of fetal hydronephrosis?
dc.typeArticle

Files